2023-02-24
Crystalvue is thrilled to announce that it has been awarded the prestigious Taiwan BIO Awards. Crystalvue's CEO, Dr. William Wang, had the privilege of meeting with President Tsai Ing-wen.
2022-07-12
Crystalvue set a new monthly revenue record in June, with a monthly increase of 39% and an annual increase of 64% due to strong and steady sales in Europe and North America.
2022-02-14
President Tsai meets the winners of 2021 Taiwan Bio Award. As the Gold Medal winner, Crystalvue General Manager, Mr. CP Chuang, was invited to meet President Tsai.
2021-11-22
CV-700 is an Automated Patternless Workstation of Lens that combines tracing, edging, beveling, grooving, and blocking functions.
2021-11-22
With steady increase in new orders and new product launch, Crystalvue is optimistic about the business outlook and targets double digit growth in 2022.
2021-11-08
The winners of 2021 Taiwan BIO Awards Outstanding Award were announced, and Crystalvue won the Gold Award.
2021-08-23
Crystalvue’s Automatic Non-Mydriatic Fundus Cameras, both NFC-700 and NFC-600, have been listed as one of the applicable devices for Acer VeriSee DR.
2021-07-20
Crystalvue was awarded Gold Award by Taiwan Bio Industry Organization for the company's outstanding performance, growth strategies and technological innovation.
2021-04-13
FDA has cleared Crystalvue Automated Portable Retinal Camera for sale in the United States.
2020-02-10
With smart and patient-friendly feature design, Crystalvue NFC-700 was selected as Taiwan Excellence Product for 2020.
2019-12-25
Crystalvue goes public through IPO on Taipei Exchange (6527-TW). The price went from $58.8 to $83.1 per share on the first day of IPO.
2019-12-15
Industrial Technology Research Institute combines Crystalvue NFC-700 and diagnose software into a self-serving retinal camera, aiming to provide healthcare for remote areas.